ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Another study revealed that miR-30 induces the degradation of BCR/ABL1 mRNAs by binding directly to their 3′UTR, which was downregulated in CML patients less responsive to IM [152].